SEARCH

SEARCH BY CITATION

References

  • American College of Physicians (1992) Prudent strategies for elective red blood cell transfusion. Annals of Internal Medicine, 116, 403406.
  • American Society of Anesthiologists Task Force on Blood Component Therapy (1996) Practice guidelines for blood component therapy. Anesthiology, 84, 732747.
  • Anderson, K.C., Goodnough, L.T., Sayers, M., Pisciotto, P.T., Kurtz, S.R., Lane, T.A., Anderson, S.C. & Silberstein, L.E. (1991) Variation in blood component practice. implications for prevention of transfusion-associated graft-versus-host disease. Blood, 77, 20962102.
  • Baskett, P.J.F. (1990) Management of hypovolaemic shock. British Medical Journal, 300, 14531457.
  • Boneu, B. & Fernandez, F. (1987) The role of the haematocrit in bleeding. Transfusion Medicine Reviews, 1, 182185.
  • Bracey, A.W., Radovancevic, R., Riggs, S.A., Houston, S., Cozart, H., Vaughn, W.K., Radovancevic, B., McAllister, H.A., Jr & Cooley, D.A. (1999) Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome. Transfusion, 39, 10701077.
  • Brennan, M., Runganga, J., Barbara, J.A.J., Contreras, M., Tedder, R.S., Garson, J.A., Tuke, P.W., Mortimer, P.P., McAlpine, L. & Tosswill, J.H.C. (1993) Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London. British Medical Journal, 307, 12351239.
  • British Committee for Standards in Haematology (BCSH) (1988) Guidelines for transfusion for massive blood loss. Clinical and Laboratory Haematology, 10, 265273.
  • British Committee for Standards in Haematology (BCSH) (1992) Guidelines for platelet transfusions. Transfusion Medicine, 2, 311318.
  • British Committee for Standards in Haematology (BCSH) (1993) Guidelines for autologous transfusion. I. Pre-operative autologous donation. Transfusion Medicine, 3, 307316.
  • British Committee for Standards in Haematology (BCSH) (1996) Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. Transfusion Medicine, 6, 273283.
  • British Committee for Standards in Haematology (BCSH) (1997) Guidelines for pre-operative autologous transfusion. II. Perioperative haemodilution and cell salvage. British Journal of Anaesthesia, 78, 768771.
  • British Committee for Standards in Haematology (BCSH) (1999) Guidelines for the administration of blood and blood components and the management of transfused patients. Transfusion Medicine, 9, 227238.DOI: 10.1046/j.1365-3148.1999.00203.x
  • Calder, L., Hebert, P.C., Carter, A.O. & Graham, I.D. (1997) Review of published recommendations and guidelines for the transfusion of allogeneic red blood cells and plasma. Canadian Medical Association Journal, 156 (II Suppl.), S18.
  • Carson, J.L., Spence, R.K., Poses, R.M. & Bonavita, G. (1988) Severity of anaemia and operative mortality and morbidity. Lancet, 1, 727729.
  • Carson, J.L., Terrin, M.L., Barton, F.B., Aaron, R., Green burg, A.G., Heck, D.A., Magaziner, J., Merlino, F.E., Bunce, G., McClelland, B., Duff, A. & Noveck, H. (1998) A pilot randomized trial comparing symptomatic vs. hemoglobin-level-driven red blood cell transfusions following hip fracture. Transfusion, 38, 522529.
  • Castro, O. (1999) Management of sickle cell disease: recent advances and controversies. British Journal of Haematology, 107, 211.
  • Cella, D. (1997) The functional assessment of cancer therapy-anemia (FACT-An) scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Seminars in Hematology, 34, (Suppl. 2) 1319.
  • Consensus Conference on Red Cell Transfusion, Royal College of Physicians of Edinburgh (1994) Consensus statement on red cell transfusion. Transfusion Medicine, 4, 177178.
  • Despotis, G.J., Grishaber, J.E. & Goodnough, L.T. (1994) The effect of an intraoperative treatment algorithm on physicians' transfusion practice in cardiac surgery. Transfusion, 34, 290296.DOI: 10.1046/j.1537-2995.1994.34494233575.x
  • Dodd, R.Y. (1994) Adverse consequences of blood transfusion: quantitative risk estimates. In: Blood Supply: Risk Perceptions, and Prospects for the Future (ed. by S.T.Nance), pp. 124. American Association of Blood Banks, Bethesda, MD.
  • Eisenstaedt, R.S. (1997) Modifying physicians' transfusion practice. Transfusion Medicine Reviews, 11, 2737.
  • Fearn, S.J. & Mortimer, A.J. (2000) Haematological considerations. In: Anaesthesia for Vascular Surgery (ed. by J.Bannister & J.A.W. Wildsmith), pp. 232250. Arnold, London.
  • Flanagan, P., McAlpine, I. & Ramskill, S.J. (1995) Evaluation of a combined HIV-1/2 and HTLV-I/II assay for screening blood donors. Vox Sanguinis, 68, 220224.
  • Goodnough, L.T., Brecher, M.E., Kanter, M.H. & Aubuchon, J.P. (1999) Transfusion medicine. Blood transfusion. New England Journal of Medicine, 340, 438447.DOI: 10.1056/NEJM199902113400606
  • Griggs, J.J. & Blumberg, N. (1998) Recombinant erythropoietin and blood transfusions in cancer chemotherapy-induced anemia. Anti-Cancer Drugs, 9, 925932.
  • Hebert, P.C., Schweitzer, I., Calder, L., Blajchman, M. & Giulivi, A. (1997) Review of the clinical practice literature on allogeneic red blood cell transfusion. Canadian Medical Association Journal, 156, (II Suppl.), S9S26.
  • Hebert, P.C., Wells, G., Blajchman, M.A., Marshall, J., Martin, C., Pagliarello, G., Tweedale, M., Schweitzer, I. & Yetisir, E, & the Transfusion Requirements in Critical Care Investigators for the Canadian Critical Care Trials Group (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. New England Journal of Medicine, 340, 409417.DOI: 10.1056/NEJM199902113400601
  • Hellstrom-Lindberg, E. (1995) Efficacy of erythropoietin in the myelodysplastic syndromes: a meta-analysis of 205 patients from 17 studies. British Journal of Haematology, 89, 6771.
  • Hinds, C. & Watson, D. (1995) Manipulating hemodynamics and oxygen transport in critically ill patients. New England Journal of Medicine, 333, 10741075.DOI: 10.1056/NEJM199510193331609
  • Italian Cooperative Study Group for rHuEpo in myelodysplastic syndromes (1998) A randomized double-blind placebo-controled study with subcutaneous recombinant human erythropoietin in patients with low–risk myelodysplastic syndromes. British Journal of Haematology, 103, 10701074.DOI: 10.1046/j.1365-2141.1998.01085.x
  • Lenfant, C. (1992) Transfusion practice should be audited for both undertransfusion and overtransfusion. Transfusion, 32, 873874.DOI: 10.1046/j.1537-2995.1992.32993110764.x
  • Linden, J.V., Tourault, M.A. & Scribner, C.L. (1997) Decrease in frequency of transfusion fatalities. Transfusion, 37, 243244.DOI: 10.1046/j.1537-2995.1997.37297203534.x
  • Livio, M., Gotti, E., Marchesi, D., Mecca, G., Remuzzi, G. & De Gaetano, G. (1982) Uraemic bleeding. role of anaemia and beneficial effect of red cell transfusions. Lancet, i, 10131015.DOI: 10.1016/S0140-6736(82)90050-2
  • Ludwig, H., Fritz, E., Kotzmann, H., Hocker, P., Gisslinger, H. & Barnas, U. (1990) Erythropoietin treatment of anemia associated with multiple myeloma. New England Journal of Medicine, 322, 16931699.
  • McClelland, D.B.L. (1994) Red cell transfusion for elective surgery: a suitable case for treatment. Transfusion Medicine, 4, 247249.
  • Murphy, M.F. (1999) New variant Creutzfeldt–Jakob disease: the risk of transmission by blood transfusion and the potential benefit of leukocyte reduction of blood components. Transfusion Medicine Reviews, 13, 15.
  • Ness, P.M., Shirley, R.S., Thoman, S.K. & Buck, S.A. (1990) The differentiation of delayed serologic and delayed haemolytic transfusion reactions. incidence, long-term serologic findings, and clinical significance. Transfusion, 1990, 688693.DOI: 10.1046/j.1537-2995.1990.30891020325.x
  • NHS Executive (1998) Better Blood Transfusion. Circular HSC 1998/224. NHS Executive, London.
  • Olivieri, N.F. (1999) The β-thalassemias. New England Journal of Medicine, 341, 99109.DOI: 10.1056/NEJM199907083410207
  • Oster, W., Herrmann, F., Gamm, H., Zeile, G., Lindemann, A., Muller, G., Brune, T., Kraemer, H.P. & Mertelsmann, R. (1990) Erythropoietin for the treatment of malignancy associated with neoplastic bone marrow infiltration. Journal of Clinical Oncology, 8, 956962.
  • Osterborg, A., Boogaerts, M.A., Cimino, R., Essers, U., Holowiecki, J., Juliusson, G., Jager, G., Najrman, A. & Peest, D., for the European Study Group of Erythropoietin Treatment in Multiple Myeloma and Non-Hodgkin's Lymphoma (1996) Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma – a randomized multicenter study. Blood, 87, 26752682.
  • Platanias, L.C., Miller, C.B., Mick, R., Hart, R.D., Ozer, H., McEvilly, J.-M., Jones, R.L. & Ratain, M.J. (1991) Treatment of chemotherapy-induced anemia with recombinant human erythropoietin in cancer patients. Journal of Clinical Oncology, 9, 20212026.
  • Popovsky, M.A. & Moore, S.B. (1985) Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion, 25, 573577.DOI: 10.1046/j.1537-2995.1985.25686071434.x
  • Regan, F.A.M., Hewitt, P., Barbara, J.A.J. & Contreras, M., on behalf of the current TTI Study Group (2000) Prospective investigation of transfusion in transmitted infection in recipients of over 20,000 units of blood. British Medical Journal, 320, 403406.
  • Rose, E.H., Abels, R.I., Nelson, R.A., McCullough, D.M. & Lessin, L. (1995) The use of r-HuEpo in the treatment of anaemia related to myelodysplasia. British Journal of Haematology, 89, 831837.
  • Salmon, J.B. & Mythen, M.G. (1993) Pharmacology and physiology of colloids. Blood Reviews, 7, 114120.
  • Sazama, K. (1990) Reports of 355 transfusion-associated deaths. 1976 through 1985. Transfusion, 37, 583590.DOI: 10.1046/j.1537-2995.1990.30790385515.x
  • Schierhout, G. & Roberts, I. (1998) Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. British Medical Journal, 316, 961964.
  • Shulman, I.A. (1990) The risk of an overt haemolytic transfusion reaction following the use of an immediate spin crossmatch. Archives of Pathology and Laboratory Medicine, 114, 412414.
  • Spivak, J.L. (1994) Recombinant human erythropoietin and the anemia of cancer. Blood, 84, 9971004.
  • Stainsby, D., MacLennan, S. & Hamilton, P.J. (2000) Management of massive blood loss: a template guideline. British Journal of Anaesthesia, 85, 487491.
  • Stehling, L. & Simon, T.L. (1994) The red blood cell transfusion trigger. Physiology and clinical studies. Archives of Pathology and Laboratory Medicine, 118, 429434.
  • The Sanguis Study Group (1994) Use of blood products for elective surgery in 43 European hospitals. Transfusion Medicine, 4, 251268.
  • Toy, P.T.C.Y. (1994) Effectiveness of transfusion audits and practice guidelines. Archives of Pathology and Laboratory Medicine, 118, 435437.
  • Turner, M. (1999) The impact of new-variant Creutzfeldt–Jakob disease on blood transfusion practice. British Journal of Haematology, 106, 842850.DOI: 10.1046/j.1365-2141.1999.01457.x
  • Valeri, C.R., Crowley, J.P. & Loscalzo, J. (1998) The red cell transfusion trigger: has a sin of commission now become a sin of omission? Transfusion, 38, 602610.DOI: 10.1046/j.1537-2995.1998.38698326341.x
  • Vichinsky, E.P., Haberkern, C.M., Neumayr, L., Earles, A.N., Black, D., Koshy, M., Pegelow, C., Abboud, M., Ohene-Frempong, K. & Iyer, R.V. (1995) A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. New England Journal of Medicine, 333, 206213.DOI: 10.1056/NEJM199507273330402
  • Viele, M.K. & Weiskopf, R.B. (1994) What can we learn about the need for transfusion from patients who refuse blood? The experience with Jehovah's Witnesses. Transfusion, 34, 396401.DOI: 10.1046/j.1537-2995.1994.34594249050.x
  • Watts, J., Gosling, P., Makin, A., Plenderleith, L., McAnulty, G.R., Grounds, R.M., Bapat, P.P., Raine, G.J., Wyncoll, D.L.A., Beale, R.J., McLuckie, A., Schierhout, G.H. & Roberts, I. (1998) Letters on fluid resuscitation with colloid or crystalloid solutions. British Medical Journal, 317, 277279.
  • Weiskopf, R.B. (1998) Do. we know when to transfuse red cells to treat acute anemia? Transfusion, 38, 517521.DOI: 10.1046/j.1537-2995.1998.38698326330.x
  • Weiskopf, R.B., Viele, M.K., Feiner, J., Kelley, S., Liberman, J., Noorani, M., Leung, J.M., Fisher, D.M., Murray, W.R., Toy, P. & Moore, M. (1998) Human cardiovascular and metabolic response to acute severe isovolaemic anemia. Journal of the American Medical Association, 279, 217221.DOI: 10.1001/jama.279.3.217
  • Williamson, L.M., Lowe, S., Love, E.M., Cohen, H., Soldan, K., McClelland, D.B.L., Skacel, P. & Barbara, J.A.J. (1999) Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. British Medical Journal, 319, 1619.